TickerFacts.

Protara Therapeutics, Inc. (TARA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$28.58M
Year ended 2016-12-31
2012-12-31: -$7.94M2013-12-31: -$7.09M2014-12-31: -$7.55M2015-12-31: -$20.81M2016-12-31: -$28.58M-$28.58M
2012-12-31 EBITDA (USD) 2016-12-31
Period endedEBITDAChange YoYSource filing
2016-12-31-$28.58Mn/m2019-03-13, From 2016-01-01
2015-12-31-$20.81Mn/m2018-03-14, From 2015-01-01
2014-12-31-$7.55Mn/m2017-03-16, From 2014-01-01
2013-12-31-$7.09Mn/m2016-03-14, From 2013-01-01
2012-12-31-$7.94Mn/a2015-03-20, From 2012-01-01